M. Partridge

发表

Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions.

G. Emilion, J. Langdon, M. Partridge, 1997, Oral oncology.

Molecular markers for diagnosis and prognosis

K. Gaballah, M. Partridge, Xiaohong Huang, 2005, Cancer and Metastasis Reviews.

Molecular analysis of paired tumours: time to start treating the field.

M. Partridge, S. Pateromichelakis, E. Phillips, 2005, Oral oncology.

Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma.

G. Emilion, J. Langdon, M. Partridge, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization.

R. A’Hern, G. Emilion, J. Langdon, 2000, Cancer research.

Expression of TNF and the 55-kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma.

M. Partridge, S. Kiguwa, F. Younes, 2008, Oral diseases.

Tissue engineering of oral dysplasia

D. Costea, A. Hills, S. Gollin, 2008, The Journal of pathology.

Current status of genetics for prediction, prognosis, and gene therapy

M. Partridge, 2000 .

Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas--potential autocrine regulation of normal and malignant epithelial cell proliferation.

M. Feldmann, M. Green, J. Langdon, 1989, British Journal of Cancer.

Development of a Facile Fluorescent Assay for the Detection of 80 Mutations Within the p53 Gene

D. Hodgson, C. Foy, N. Gibson, 2002, Molecular medicine.

Lysis of dysplastic but not normal oral keratinocytes and tissue-engineered epithelia with conditionally replicating adenoviruses.

D. Curiel, A. Hills, K. Gaballah, 2007, Cancer research.

Patient‐specific mutation databases for oral cancer

R. A’Hern, G. Emilion, J. Langdon, 1999, International journal of cancer.

Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines.

M. Feldmann, D. Chantry, M. Partridge, 1991, The Journal of investigative dermatology.

Management of recurrent aphthous ulcers. A trial of carbenoxolone sodium mouthwash

D. Poswillo, M. Partridge, 1984, British Dental Journal.

Lymph node micrometastases in head and neck cancer: a review.

H. Hamakawa, A. Ferlito, J. Brennan, 2001, Acta oto-laryngologica.

LOH at 3p correlates with a poor survival in oral squamous cell carcinoma.

G. Emilion, J. Langdon, M. Partridge, 1996, British Journal of Cancer.

Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.

J. Langdon, Xiaojun Huang, M. Partridge, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Topical carbenoxolone sodium in the management of herpes simplex infection.

D. Poswillo, M. Partridge, 1984, The British journal of oral & maxillofacial surgery.

Genetics/epigenetics of oral premalignancy: current status and future research.

M. Lingen, D. Peterson, S. Woo, 2011, Oral diseases.

Carcinoma within a Field of Cancerization Identify Patients at Risk of Developing Oral Squamous Cell A Case-Control Study Confirms That Microsatellite Assay Can

R. A’Hern, G. Emilion, J. Langdon, 2000 .

A Case-Control Study Confirms That Microsatellite Assay Can Identify Patients at Risk of Developing Oral Squamous Cell Carcinoma within a Field of Cancerization 1

R. A’Hern, G. Emilion, J. Langdon, 2000 .

Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure.

R. Hooper, R. Brakenhoff, J. Langdon, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.

G. Kalna, D. Costea, A. Hills, 2013, Cancer research.

New insights into p53 protein stabilisation in oral squamous cell carcinoma.

R. A’Hern, G. Emilion, J. Langdon, 1999, Oral oncology.

Subtypes of oral carcinoma-associated fibroblasts 1 Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma

D. Costea, A. Hills, J. Thurlow, 2013 .

Identi fi cation of Two Distinct Carcinoma-Associated Fibroblast Subtypes with Differential Tumor-Promoting Abilities in Oral Squamous Cell Carcinoma

G. Kalna, D. Costea, A. Hills, 2013 .

p53 Mutations in Deep Tissues Are More Strongly Associated with Recurrence than Mutation-Positive Mucosal Margins

J. Langdon, M. Sherriff, E. Odell, 2007, Clinical Cancer Research.

The changing face of p53 in head and neck cancer.

D. Costea, M. Partridge, X. Huang, 2007, International journal of oral and maxillofacial surgery.

Local complications following intravenous benzodiazepines in the dorsum of the hand. A comparison between midazolam and Diazemuls in sedation for dentistry

M. Partridge, J. Margary, N. Rosenbaum, 1986, Anaesthesia.

The utility of molecular diagnostics to predict recurrence of head and neck carcinoma

M. McGurk, A. Hills, M. Sherriff, 2012, British Journal of Cancer.

The pattern of expression of the 5T4 oncofoetal antigen on normal, dysplastic and malignant oral mucosa.

J. Langdon, P. Stern, A. Ali, 2001, Oral oncology.

LOH at3pcorrelates with a poorsurvival inoral squamouscell carcinoma

G. Emilion, M. Partridge, 1996 .

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma.

Gabriela Kalna, Catharine M L West, Adrian L Harris, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral cancer: 1. The genetic basis of the disease.

M. Partridge, 2000, Dental Update.

The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer

R. A’Hern, G. Emilion, J. Langdon, 1999, British Journal of Cancer.

A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.

R. Hooper, M. Partridge, E. Phillips, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas

G. Emilion, J. Langdon, M. Partridge, 1999, International journal of cancer.

Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer.

R. A’Hern, G. Emilion, J. Langdon, 1998, Oral oncology.

Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC

M. Partridge, E. Phillips, R. Francis, 1999, The Journal of pathology.

The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues

A. Ryan, A. Hills, K. Gaballah, 2009, British Journal of Cancer.

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma.

A. Harris, G. Kalna, B. Ozanne, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.

G. Kalna, D. Costea, A. Hills, 2013, Cancer research.

Subtypes of oral carcinoma-associated fibroblasts 1 Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma

D. Costea, A. Hills, J. Thurlow, 2013 .